联科生物固定破膜剂(Fix&Perm)质量优秀,操作简单,深受广大科研人员好评与喜爱,具有以下三大优点:
1、破膜后细胞分群保持完好
2、溶血、破膜、染色一步完成,节约成本,操作简便
3、保持抗体的特异性、灵敏度以及可重复性
联科生物固定破膜剂产品列表:
厂商 |
目录号 |
产品名称 |
规格 |
目录价 |
MultiSciences |
50T |
560 |
||
MultiSciences |
100T |
1060 |
||
MultiSciences |
200T |
1960 |
||
MultiSciences |
1000T |
8760 |
||
MultiSciences |
50T |
360 |
引用联科固定破膜剂部分参考文献:
[1] Yin Q, Shen J, Chen L, et al. Overcoming multidrug resistance by co-delivery of Mdr-1 and survivin-targeting RNA with reduction-responsible cationic poly (β-amino esters)[J]. Biomaterials, 2012, 33(27): 6495-6506.. (IF: 8.55)
[2] Yin Q, Zhang Z, et al. Multifunctional nanoparticles improve therapeutic effect for breast cancer by simultaneously antagonizing multiple mechanisms of multidrug resistance[J]. Biomacromolecules, 2013, 14(7): 2242-2252.(IF:5.75)
[3] Yang Y, Gao Y, Chen L, et al. Downregulation of survivin expression and enhanced chemosensitivity of MCF-7 cells to adriamycin by PDMAE/survivin shRNA complex nanoparticles[J]. International journal of pharmaceutics, 2011, 405(1): 188-195. (IF:3.65)
[4] Yuan C, Zhang H, Wang W, et al. Transmembrane protein 63A is a partner protein of Haemonchus contortus galectin in the regulation of goat peripheral blood mononuclear cells[J]. Parasites & vectors, 2015, 8(1): 211. (IF:3.43)
[5] Yan L, Xie K M, Yang G Q, et al. GCS induces multidrug resistance by regulating apoptosis-related genes in K562/AO2 cell line.[J]. Cancer Chemotherapy & Pharmacology, 2009, 66(3):433-439.(IF: 2.76)
[6] Zhang H X, Zhu B, Fu X X, et al. BTLA associates with increased Foxp3 expression in CD4+ T cells in dextran sulfate sodium-induced colitis[J]. International journal of clinical and experimental pathology, 2015, 8(2): 1259. (IF: 1.89)
[7] Zhang Q, Deng C, Rao F, et al. Silencing of desmoplakin decreases connexin43/Nav1. 5 expression and sodium current in HL 1 cardiomyocytes[J]. Molecular medicine reports, 2013, 8(3): 780-786. (IF: 1.55)
[8] Li X, Wang Y, Han C, et al. Colorectal cancer progression is associated with accumulation of Th17 lymphocytes in tumor tissues and increased serum levels of interleukin-6[J]. The Tohoku journal of experimental medicine, 2014, 233(3): 175-182. (IF: 1.35)